These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32860346)

  • 21. Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure.
    Beldhuis IE; Damman K; Pang PS; Greenberg B; Davison BA; Cotter G; Gimpelewicz C; Felker GM; Filippatos G; Teerlink JR; Metra M; Voors AA; Ter Maaten JM
    Eur J Heart Fail; 2023 Sep; 25(9):1584-1592. PubMed ID: 37462255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair.
    Tanaka T; Kavsur R; Spieker M; Iliadis C; Metze C; Brachtendorf BM; Horn P; Zachoval C; Sugiura A; Kelm M; Baldus S; Nickenig G; Westenfeld R; Pfister R; Becher MU
    Heart; 2022 Oct; 108(21):1722-1728. PubMed ID: 35672114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
    Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM
    J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.
    Desai AS; Vardeny O; Claggett B; McMurray JJ; Packer M; Swedberg K; Rouleau JL; Zile MR; Lefkowitz M; Shi V; Solomon SD
    JAMA Cardiol; 2017 Jan; 2(1):79-85. PubMed ID: 27842179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients.
    Matsukawa R; Okahara A; Tokutome M; Itonaga J; Koga E; Hara A; Kisanuki H; Sada M; Okabe K; Kawai S; Ogawa K; Matsuura H; Mukai Y
    ESC Heart Fail; 2023 Dec; 10(6):3352-3363. PubMed ID: 37671603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice.
    Smith KV; Dunning JR; Fischer CM; MacLean TE; Bosque-Hamilton JW; Fera LE; Grant JY; Zelle DJ; Matta L; Gaziano TA; MacRae CA; Scirica BM; Desai AS
    J Pharm Pract; 2022 Oct; 35(5):747-751. PubMed ID: 33813934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry.
    Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G
    Eur J Heart Fail; 2023 Jul; 25(7):1132-1144. PubMed ID: 37317585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.
    Fiuzat M; Schulte PJ; Felker M; Ahmad T; Neely M; Adams KF; Donahue MP; Kraus WE; Piña IL; Whellan DJ; O'Connor CM
    J Card Fail; 2014 Jan; 20(1):38-44. PubMed ID: 24304938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
    Matsushita K; Delmas C; Marchandot B; Roubille F; Lamblin N; Leurent G; Levy B; Elbaz M; Champion S; Lim P; Schneider F; Khachab H; Carmona A; Trimaille A; Bourenne J; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Biendel C; Labbe V; Combaret N; Mansourati J; Filippi E; Maizel J; Merdji H; Lattuca B; Gerbaud E; Bonnefoy E; Puymirat E; Bonello L; Morel O
    J Am Heart Assoc; 2024 Mar; 13(5):e030975. PubMed ID: 38390813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis.
    Zafeiropoulos S; Farmakis IT; Milioglou I; Doundoulakis I; Gorodeski EZ; Konstantinides SV; Cooper L; Zanos S; Stavrakis S; Giamouzis G; Butler J; Giannakoulas G
    JACC Heart Fail; 2024 Apr; 12(4):616-627. PubMed ID: 37656079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guideline directed medical therapy and reduction of secondary mitral regurgitation.
    Spinka G; Bartko PE; Heitzinger G; Prausmüller S; Winter MP; Arfsten H; Strunk G; Rosenhek R; Kastl S; Hengstenberg C; Pavo N; Hülsmann M; Goliasch G
    Eur Heart J Cardiovasc Imaging; 2022 Jun; 23(6):755-764. PubMed ID: 35466372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
    Izumi K; Kohno T; Goda A; Takeuchi S; Shiraishi Y; Saji M; Nagatomo Y; Tanaka TD; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
    Int J Cardiol; 2023 Jan; 370():255-262. PubMed ID: 36270494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guideline-directed medical therapy in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation.
    Higuchi S; Orban M; Adamo M; Giannini C; Melica B; Karam N; Praz F; Kalbacher D; Koell B; Stolz L; Braun D; Näbauer M; Wild M; Doldi P; Neuss M; Butter C; Kassar M; Ruf T; Petrescu A; Ludwig S; Pfister R; Iliadis C; Unterhuber M; Sampaio F; Ferreira D; Thiele H; Baldus S; von Bardeleben RS; Massberg S; Windecker S; Lurz P; Petronio AS; Lindenfeld J; Abraham WT; Metra M; Hausleiter J;
    Eur J Heart Fail; 2022 Nov; 24(11):2152-2161. PubMed ID: 35791663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mineralocorticoid receptor antagonist use following heart failure hospitalization.
    Duran JM; Gad S; Brann A; Greenberg B
    ESC Heart Fail; 2020 Apr; 7(2):482-492. PubMed ID: 32035000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial).
    Vaduganathan M; Dei Cas A; Mentz RJ; Greene SJ; Khan S; Subacius HP; Chioncel O; Maggioni AP; Konstam MA; Senni M; Fonarow GC; Butler J; Gheorghiade M;
    Am J Cardiol; 2014 Sep; 114(5):743-50. PubMed ID: 25060414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study.
    Bhatt AS; Varshney AS; Nekoui M; Moscone A; Cunningham JW; Jering KS; Patel PN; Sinnenberg LE; Bernier TD; Buckley LF; Cook BM; Dempsey J; Kelly J; Knowles DM; Lupi K; Malloy R; Matta LS; Rhoten MN; Sharma K; Snyder CA; Ting C; McElrath EE; Amato MG; Alobaidly M; Ulbricht CE; Choudhry NK; Adler DS; Vaduganathan M
    Eur J Heart Fail; 2021 Jul; 23(7):1191-1201. PubMed ID: 33768599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.